The estimated Net Worth of R Judd Jessup is at least $17.8 million dollars as of 23 August 2024. Mr. Jessup owns over 2,500 units of Corvel stock worth over $12,265,314 and over the last 21 years he sold CRVL stock worth over $5,448,355. In addition, he makes $99,703 as Lead Independent Director at Corvel.
R has made over 44 trades of the Corvel stock since 2003, according to the Form 4 filled with the SEC. Most recently he sold 2,500 units of CRVL stock worth $779,000 on 23 August 2024.
The largest trade he's ever made was selling 15,000 units of Corvel stock on 22 August 2003 worth over $29,100. On average, R trades about 1,964 units every 76 days since 2003. As of 23 August 2024 he still owns at least 40,777 units of Corvel stock.
You can see the complete history of Mr. Jessup stock trades at the bottom of the page.
R. Judd Jessup serves as Lead Independent Director of the Company. Mr. Jessup was Chief Executive Officer of CombiMatrix Corporation, a molecular diagnostics laboratory, from August 2010 to March 2013. Mr. Jessup was Chief Executive Officer of U.S. LABS, a national laboratory which provides cancer diagnostic and genetic testing services, from 2002 to 2005. Mr. Jessup was President of the HMO Division of FHP International Corporation, a diversified health care services company, from 1994 to 1996. From 1987 to 1994, Mr. Jessup was President of TakeCare, Inc., a publicly held HMO operating in California, Colorado, Illinois and Ohio, until it was acquired by FHP. Mr. Jessup has 43 years of experience in the healthcare and managed care industries. Mr. Jessup was a director of CombiMatrix Corporation from August 2010 to November 2017, a director of Xifin, Inc., a laboratory billing systems company, from January 2006 to August 2013, a director of Superior Vision Services, a national managed vision care plan, from December 2007 to April 2012, and a director of Accentcare from October 2005 to February 2008. The Board believes Mr. Jessup is qualified to serve as a director because he has significant executive experience with the strategic, financial, and operational requirements of large health care services organizations, including serving as an Audit Committee chair, and brings to the Board senior leadership, health industry, and financial experience.
As the Lead Independent Director of Corvel, the total compensation of R Jessup at Corvel is $99,703. There are 13 executives at Corvel getting paid more, with Michael Combs having the highest compensation of $1,432,050.
R Jessup is 72, he's been the Lead Independent Director of Corvel since 1997. There are 3 older and 14 younger executives at Corvel. The oldest executive at Corvel Corp. is Jean Macino, 77, who is the Independent Director.
R's mailing address filed with the SEC is 5128 APACHE PLUME ROAD, SUITE 400, , FORT WORTH, TX, 75109.
Over the last 21 years, insiders at Corvel have traded over $229,459,690 worth of Corvel stock. The most active insiders traders include Holdings Inc Corstar, V Gordon Clemons et Michael G Combs. On average, Corvel executives and independent directors trade stock every 7 days with the average trade being worth of $1,644,118. The most recent stock trade was executed by Brandon O'brien on 29 August 2024, trading 400 units of CRVL stock currently worth $35,076.
together, let's do more. corvel is a leader of risk and healthcare management solutions to employers, third party administrators, insurance companies and government agencies. we are publicly traded (nasdaq:crvl) and annual revenues exceeded $493 million in fy2015. our continued customer growth is a testament to our financial stability and our significant investments in new systems and technologies allows us to continue to deliver industry-leading solutions to the marketplace. corvel has approximately 3,500 associates who serve more than 2,000 customers through a national branch office network covering all 50 states.
Corvel executives and other stock owners filed with the SEC include: